Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $29.64 million as of April 2, 2025. Its market cap has increased by 25.11% in one year.

Market Cap

29.64M

Enterprise Value

28.24M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.45

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 29.64M, an increase of 329.79%. That is a compound annual growth rate of 5.04%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	29.64M	-2.26%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.83B
Endo Inc.	1.83B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Elite Pharmaceuticals	464.70M
Glass House Brands	378.85M
CytoDyn	303.53M
Northwest Biotherapeutics	287.99M

Market Cap Rankings